AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

doi:10.1053/j.gastro.2020.01.006

Practice Guideline

. 2020 Apr;158(5):1450-1461.

doi: 10.1053/j.gastro.2020.01.006. Epub 2020 Jan 13.

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Joseph D Feuerstein¹, Kim L Isaacs², Yecheskel Schneider³, Shazia Mehmood Siddique³, Yngve Falck-Ytter⁴, Siddharth Singh⁵; AGA Institute Clinical Guidelines Committee

Collaborators, Affiliations

Collaborators

AGA Institute Clinical Guidelines Committee:
Karen Chachu, Lukejohn Day, Benjamin Lebwohl, Thiruvengadam Muniraj, Amit Patel, Anne F Peery, Raj Shah, Shahnaz Sultan, Harminder Singh, Siddharth Singh, Stuart Spechler, Grace Su, Aaron P Thrift, Jennifer M Weiss, Adam V Weizman, Joseph Feuerstein, Siddharth Singh, Kim Isaacs, Yecheskel Schneider, Yngve Falck-Ytter, Shazia Mehmood Siddique, Jessica Allegretti, Jonathan Terdiman, Siddharth Singh, Shazia Mehmood Siddique

Affiliations

¹ Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
² Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
³ Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
⁴ Division of Gastroenterology, Case Western Reserve University, Cleveland, Ohio; Department of Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio.
⁵ Division of Gastroenterology, University of California, San Diego, La Jolla, California.

PMID: 31945371
PMCID: PMC7175923
DOI: 10.1053/j.gastro.2020.01.006

Practice Guideline

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Joseph D Feuerstein et al. Gastroenterology. 2020 Apr.

. 2020 Apr;158(5):1450-1461.

doi: 10.1053/j.gastro.2020.01.006. Epub 2020 Jan 13.

Authors

Joseph D Feuerstein¹, Kim L Isaacs², Yecheskel Schneider³, Shazia Mehmood Siddique³, Yngve Falck-Ytter⁴, Siddharth Singh⁵; AGA Institute Clinical Guidelines Committee

Collaborators

AGA Institute Clinical Guidelines Committee:
Karen Chachu, Lukejohn Day, Benjamin Lebwohl, Thiruvengadam Muniraj, Amit Patel, Anne F Peery, Raj Shah, Shahnaz Sultan, Harminder Singh, Siddharth Singh, Stuart Spechler, Grace Su, Aaron P Thrift, Jennifer M Weiss, Adam V Weizman, Joseph Feuerstein, Siddharth Singh, Kim Isaacs, Yecheskel Schneider, Yngve Falck-Ytter, Shazia Mehmood Siddique, Jessica Allegretti, Jonathan Terdiman, Siddharth Singh, Shazia Mehmood Siddique

Affiliations

¹ Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
² Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
³ Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
⁴ Division of Gastroenterology, Case Western Reserve University, Cleveland, Ohio; Department of Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio.
⁵ Division of Gastroenterology, University of California, San Diego, La Jolla, California.

PMID: 31945371
PMCID: PMC7175923
DOI: 10.1053/j.gastro.2020.01.006

No abstract available

PubMed Disclaimer

Cited by

Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis.
Krugliak Cleveland N, Candela N, Carter JA, Kuharic M, Qian J, Tang Z, Turpin R, Rubin DT. Krugliak Cleveland N, et al. Crohns Colitis 360. 2024 Oct 22;6(4):otae061. doi: 10.1093/crocol/otae061. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39502268 Free PMC article.
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study).
Shehab M, Alfadhli A, Abdullah I, Alostad W, Marei A, Alrashed F. Shehab M, et al. Front Pharmacol. 2024 Oct 16;15:1388043. doi: 10.3389/fphar.2024.1388043. eCollection 2024. Front Pharmacol. 2024. PMID: 39478964 Free PMC article.
Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study.
Na JE, Park YE, Park JH, Kim TO, Lee JY, Lee JH, Park SB, Lee SB, Hong SM. Na JE, et al. J Pers Med. 2024 Oct 18;14(10):1066. doi: 10.3390/jpm14101066. J Pers Med. 2024. PMID: 39452572 Free PMC article.
Risk of Clostridioides difficile infection in inflammatory bowel disease patients undergoing vedolizumab treatment: a systematic review and meta-analysis.
Chen W, Liu Y, Zhang Y, Zhang H, Chen C, Zhu S, Zhou Y, Zhao H, Zong Y. Chen W, et al. BMC Gastroenterol. 2024 Oct 24;24(1):377. doi: 10.1186/s12876-024-03460-z. BMC Gastroenterol. 2024. PMID: 39448963 Free PMC article.
Prognostic Value of CRP/25 OH Vitamin D Ratio for Glucocorticoid Efficacy in Acute Severe Ulcerative Colitis Patients.
Nikolic A, Popovic D, Djuranovic S, Sokic-Milutinovic A, Dragasevic S. Nikolic A, et al. Diagnostics (Basel). 2024 Oct 5;14(19):2222. doi: 10.3390/diagnostics14192222. Diagnostics (Basel). 2024. PMID: 39410626 Free PMC article.

See all "Cited by" articles

References

1. Singh S, Feuerstein JD, Binion DG, et al. American Gastroenterological Association technical review on the management of mild-moderate ulcerative colits. Gastroenterology 2018. - PMC - PubMed
1. Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2017;16:343–356 e3. - PMC - PubMed
1. Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2018;16:343–356 e3. - PMC - PubMed
1. Narula N, Marshall JK, Colombel JF, et al. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids. American Journal of Gastroenterology 2016;111:477–91. - PubMed
1. Dassopoulos T, Cohen RD, Scherl EJ, et al. Ulcerative Colitis Care Pathway. Gastroenterology 2015;149:238–45. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

K23 DK117058/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Singh S, Feuerstein JD, Binion DG, et al. American Gastroenterological Association technical review on the management of mild-moderate ulcerative colits. Gastroenterology 2018. - PMC - PubMed

[2] Singh S, Feuerstein JD, Binion DG, et al. American Gastroenterological Association technical review on the management of mild-moderate ulcerative colits. Gastroenterology 2018. - PMC - PubMed

[3] Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2017;16:343–356 e3. - PMC - PubMed

[4] Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2017;16:343–356 e3. - PMC - PubMed

[5] Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2018;16:343–356 e3. - PMC - PubMed

[6] Fumery M, Singh S, Dulai PS, et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2018;16:343–356 e3. - PMC - PubMed

[7] Narula N, Marshall JK, Colombel JF, et al. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids. American Journal of Gastroenterology 2016;111:477–91. - PubMed

[8] Narula N, Marshall JK, Colombel JF, et al. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids. American Journal of Gastroenterology 2016;111:477–91. - PubMed

[9] Dassopoulos T, Cohen RD, Scherl EJ, et al. Ulcerative Colitis Care Pathway. Gastroenterology 2015;149:238–45. - PubMed

[10] Dassopoulos T, Cohen RD, Scherl EJ, et al. Ulcerative Colitis Care Pathway. Gastroenterology 2015;149:238–45. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Collaborators

Affiliations

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Authors

Collaborators

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous